MedPath

Effectiveness of unified transdiagnostic treatment with and without transcranial direct current stimulatio

Not Applicable
Conditions
Generalized anxiety disorder comorbid with depression.
Generalized anxiety disorder
Registration Number
IRCT20140929019334N1
Lead Sponsor
Ferdowsi University of Mashhad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Diagnostic DSM-V criteria for GAD as the primary diagnosis and depression disorder as a comorbid disorder
If the drug was taken, it was possible to maintain the type and amount of the drug during the study period
Be a minimum 18 years and a maximum 40 years old
Patient's consent to participate in research and to sign written consent
Speak Persian fluently
Ability to participate in all assessment and treatment sessions

Exclusion Criteria

Need for immediate medical treatment or the need for concurrent therapeutic interventions in such a way as to interfere with the treatment program
Not having previous experience in at least eight sessions of treatment based on the cognitive-behavioural therapy in the last 5 years
Having psychiatric disorders and substance abuse
Current diagnosis of any mental disorder in the axes I and II, with the exception of GAD and depression
Patient's opposition to collaboration at any time of research
Having serious thoughts about Suicide
History of experiencing other psychological treatments

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score of generalized anxiety from GAD-Q-IV questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: GAD-Q-IV questionnaire.;Score of depression from Beck depression questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Beck depression questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath